10-Q: Vynleads Faces Going Concern Amid Zero Revenue, Cash Drain

Vynleads, Inc. reported zero revenue and significant losses for Q2 2025, raising substantial doubt about its ability to continue as a going concern.

Summary

• Vynleads, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year.
• The net loss for the six months ended June 30, 2025, was $138,051, a slight improvement from $138,887 in the same period of 2024.
• Operating loss increased to $136,164 for the six months ended June 30, 2025, compared to $129,947 in the prior year.
• Cash balance plummeted to $346 as of June 30, 2025, from $68,988 at December 31, 2024.
• Working capital deficit worsened to $300,416 as of June 30, 2025, from $227,365 at December 31, 2024.
• Accumulated deficit reached $2,923,581 as of June 30, 2025.
• Net cash used in operating activities increased to $68,142 for the six months ended June 30, 2025, from $66,239 in the prior year.
• Two notes payable, totaling $75,000 in principal, are currently in default with accrued interest of $14,055 and $3,373 respectively as of June 30, 2025.
• Management identified a material weakness in internal control over financial reporting due to limited personnel and lack of segregation of duties.
• Disclosure controls and procedures were deemed not effective as of June 30, 2025.

Sentiment

Score: 1

Explanation: The company exhibits severe financial distress with zero revenue, critically low cash, a worsening working capital deficit, recurring losses, and a 'going concern' warning. The identified material weakness in internal controls and defaulted debt further compound the negative outlook, indicating a high risk of operational failure without significant, uncommitted capital infusion.

Positives

• Net loss slightly decreased to $138,051 for the six months ended June 30, 2025, compared to $138,887 in the prior year.
• Interest expense significantly decreased to $1,887 for the six months ended June 30, 2025, from $13,656 in the prior year.

Negatives

• The company reported zero revenue for the three and six months ended June 30, 2025, indicating no operational sales.
• Cash balance is critically low at $346 as of June 30, 2025, down from $68,988 at the end of 2024.
• Working capital deficit worsened to $300,416, highlighting severe liquidity issues.
• Accumulated deficit continues to grow, reaching $2,923,581.
• Operating losses increased for the six months ended June 30, 2025, compared to the prior year.
• Net cash used in operating activities increased, indicating a higher cash burn rate.
• Two notes payable, totaling $75,000 in principal, are in default, with significant accrued interest.
• Management concluded that disclosure controls and procedures were not effective.
• A material weakness in internal control over financial reporting was identified due to insufficient personnel and lack of segregation of duties.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to recurring operating losses, negative operating cash flows, and a significant working capital deficit.
• The company requires approximately $5,500,000 in additional working capital within the next 12 months, with no firm commitments for this capital.
• Failure to raise additional capital could force the company to curtail or discontinue operations entirely and potentially file for bankruptcy.
• Reliance on a single supplier for herbal/natural supplements poses a risk of material business impact due to potential manufacturing delays during a transition to a new supplier.
• Two notes payable are currently in default, which could lead to legal action or further financial strain.
• The company is involved in a dispute with a former consultant regarding alleged non-payment of royalties and is pursuing action to remove unauthorized UCC liens.
• A material weakness in internal control over financial reporting due to limited personnel creates a risk of material misstatements not being prevented or detected.

Future Outlook

The company requires approximately $5,500,000 in additional working capital over the next 12 months to meet current business objectives, including developing new indicators for its Lifestyle Blueprint platform, adding print versions of its DWD Protocol, expanding its supplement product line, and offering additional subscription content. This capital is also needed to fund increased advertising, marketing, and infrastructure development, as well as general operating expenses. There are no assurances that the company will secure this additional capital, and any delay could adversely impact its ability to increase revenues and potentially force a reduction in operating expenses, which would negatively affect future revenues and results of operations.

Management Comments

• Management believes there is substantial doubt about our ability to continue as a going concern.
• We will require substantial funds to expand service and product offerings into additional areas, market and promote our services and product offerings; and develop and grow our infrastructure and corporate organization.
• Our ability to meet our current and projected obligations depends on our ability to generate sufficient sales and to control expenses and will require that we seek additional capital through private and/or public financing sources.
• Any such failure would have a material adverse impact on our liquidity and financial condition and could force us to curtail or discontinue operations entirely and could require us to file for protection under bankruptcy laws.
• We expect to raise additional capital through, among other things, the sale of equity securities.
• Management notes that upon subsequent funding, the Company expects to have the available resources in order to hire additional personnel to expand the finance and accounting department in order to mitigate the material weakness noted above.

Industry Context

Vynleads operates in the health and wellness information and nutritional supplements industry, a competitive market driven by consumer health trends and digital content. The company's current state of zero revenue and significant losses suggests it is struggling to establish a viable market presence or generate sales, contrasting sharply with the growth seen in many segments of the broader health and wellness sector. Its reliance on a single supplier for supplements also indicates a lack of diversified supply chain typical of more established industry players.

Comparison to Industry Standards

• Vynleads' zero revenue and recurring net losses of over $138,000 for the six months ended June 30, 2025, are significantly below industry standards for established health and wellness companies, which typically demonstrate consistent revenue generation and, ideally, profitability or a clear path to it.
• The company's cash balance of $346 and working capital deficit of $300,416 indicate severe liquidity issues, far below the healthy liquidity ratios expected for operational businesses in any sector, let alone those aiming for growth.
• The 'going concern' warning is a critical indicator of financial distress, a condition not typically seen in successful or even moderately performing companies in the health and wellness industry, such as publicly traded peers like WW International (Weight Watchers) or supplement companies like Herbalife, which generate substantial revenue and generally maintain positive working capital.
• The identified material weakness in internal controls due to limited personnel is a significant governance concern, contrasting with the robust internal control frameworks expected of publicly traded companies, regardless of size, to ensure financial reporting integrity.

Corporate Governance

Legal Proceedings

• The company is involved in a dispute with a consultant (Promoter) who initiated informal claims and filed unauthorized Uniform Commercial Code (UCC) financing statements in several states, alleging non-payment of royalty amounts under a Promotion and Royalty Agreement from April 2016. The company disputes these claims, asserting all amounts due have been paid, and is actively pursuing actions to remove the remaining unauthorized UCC liens.

Related Party Transactions

• Mr. Sergei Stetsenko, a member of the Board of Directors, converted notes payable totaling $17,725 (principal and accrued interest) and $26,702 (principal and accrued interest) into 177,246 and 267,020 shares of common stock, respectively, effective October 31, 2024.
• Mr. Mannine, the CEO, provided an in-kind contribution of service valued at $65,000 for the six months ended June 30, 2025 and 2024, by voluntarily canceling his employment agreement and waiving all cash due and related accruals.
• On January 23, 2024, Mr. Sergei Stetsenko sold 1,250,000 shares of common stock to Christos Livadas, Director of Weiser Global Capital, making notes payable associated with Christos Livadas/WG Capital reflected as related party debt.

Stakeholder Impact

• **Shareholders**: Face significant dilution risk from potential future equity raises and substantial risk of losing their entire investment due to the 'going concern' warning and severe financial distress.
• **Employees**: Potential job insecurity given the company's financial instability and the need to reduce operating expenses if capital is not raised.
• **Creditors**: Two notes payable are in default, indicating a high risk of non-payment for other creditors and potential legal action.
• **Customers**: Potential disruption to service and product offerings if the company is unable to secure necessary funding or continue operations.
• **Suppliers**: The company's reliance on a single supplier for supplements, coupled with its financial state, poses a risk of payment delays or non-payment, potentially impacting the supplier's business.

Next Steps

• Seek additional capital through private and/or public financing sources to fund operating expenses and growth plans.
• Develop new indicators for the Lifestyle Blueprint platform.
• Add print versions of the DWD Protocol.
• Expand the nutritional supplement product line.
• Develop additional subscription content offerings for customers.
• Hire additional personnel to expand the finance and accounting department to mitigate the identified material weakness in internal controls, contingent on future funding.
• Continue pursuing actions to remove remaining unauthorized UCC liens related to the promoter dispute.

Key Dates

Recommendation

Vynleads, Inc. presents an extremely high-risk investment profile. The company has zero revenue, critically low cash reserves ($346), a worsening working capital deficit ($300,416), and a substantial accumulated deficit ($2.9 million). Management explicitly states 'substantial doubt about our ability to continue as a going concern' and requires $5.5 million in additional capital within 12 months with no firm commitments. Furthermore, two notes payable are in default, internal controls are ineffective, and a material weakness exists. These factors collectively indicate a company on the brink of operational failure, making it a 'strong sell' as investors face a high probability of significant or total capital loss.

Keywords

Vynleads, 10-Q, SEC filing, financial results, going concern, net loss, working capital deficit, cash flow, health and wellness, nutritional supplements, corporate governance, internal controls, debt default, capital raise